Research / DOV / Fundamental state Inspectable configuration
State dimensions Filing 0000029905-23-000008 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
34.58% · OPTIONAL · VALID
Capex intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.60% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth 70th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
7.60% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
16.06% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.01% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
16.21% · CORE · VALID
R&D intensity 50th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.92% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.36% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 51 states Self-history eligible
Sep 30, 2021 6/7 normalized Level 3 Dec 31, 2021 7/9 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 131.71%
Current 34.58%
Delta -97.12% Capex Intensity Decreased
Previous 3.03%
Current 2.60%
Delta -0.44% Cash Generation Decreased
Previous 12.26%
Current 9.47%
Delta -2.79% Growth Increased
Previous 6.94%
Current 7.60%
Delta 0.66% Inventory Pressure Decreased
Previous 65.23%
Current 16.06%
Delta -49.16% Margin Increased
Previous 35.80%
Current 36.01%
Delta 0.20% Profitability Decreased
Previous 17.16%
Current 16.21%
Delta -0.95% Sbc Intensity Increased
Previous 0.29%
Current 0.36%
Delta 0.07% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.